Seres Therapeutics (MCRB)

Earnings in 2024 (TTM): -A$0.2 Billion

According to Seres Therapeutics's latest financial reports the company's current earnings are N/A. a decrease over its 2023 earnings that were of -A$0.16 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Seres Therapeutics from 2014 to 2024

Annual earnings

Year	Earnings	Change
2024	-A$0.21 Billion	34.63%
2023	-A$0.16 Billion	-59.97%
2022	-A$0.38 Billion	289.57%
2021	-A$97.41 Million	-27.3%
2020	-A$0.14 Billion	23%
2019	-A$0.11 Billion	-30.11%
2018	-A$0.16 Billion	9.73%
2017	-A$0.15 Billion	-0.74%
2016	-A$0.15 Billion	70.96%
2015	-A$83.72 Million	257.11%
2014	-A$23.45 Million

Earnings for similar companies or competitors

Company	Earnings	Earnings differencediff.	Country
Xencor XNCR	-A$0.38 Billion	84.67%	🇺🇸 USA
Acceleron Pharma XLRN	-A$0.4 Billion	94.19%	🇺🇸 USA
Agios Pharmaceuticals AGIO	-A$0.67 Billion	223.94%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Earnings for Seres Therapeutics (MCRB)

Earnings in 2024 (TTM): -A$0.2 Billion